SARTORIUS STEDIM BIOTECH Funds and ETFs Sartorius Stedim Biotech
Equities
DIM
FR0013154002
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 208.3 EUR | +2.41% |
|
+3.84% | -13.03% |
| Apr. 23 | SARTORIUS STEDIM BIOTECH : Barclays reaffirms its Neutral rating | ZD |
| Apr. 22 | Sartorius Stedim: in the red with brokerage comments | CF |
ETFs positioned on Sartorius Stedim Biotech
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.42% | 18 M€ | +3.79% | - | |
| 0.35% | 5 M€ | +4.56% | ||
| 0.13% | 6 M€ | -.--% | - | |
| 0.07% | 31 M€ | +3.50% | - | |
| 0.07% | 6 M€ | -.--% | ||
| 0.04% | 10 M€ | -3.35% | - | |
| 0.02% | 786 M€ | -.--% | ||
| 0.02% | 23 M€ | -.--% | - | |
| 0.02% | 273 M€ | +15.83% | ||
| 0.02% | 284 M€ | -.--% | ||
| 0.02% | 206 M€ | -.--% | ||
| 0.01% | 1,166 M€ | +0.26% | - | |
| 0.01% | 607 M€ | +0.05% | - | |
| 0.01% | 389 M€ | +6.83% | - | |
| 0.01% | 205 M€ | -.--% | ||
| 0.01% | 34 M€ | +6.71% | - | |
| 0.01% | 302 M€ | +3.80% | - | |
| 0.01% | 39 M€ | +3.67% | - | |
| 0.01% | 7 M€ | +0.11% | - | |
| 0.01% | 108 M€ | +2.03% | - | |
| 0.01% | 17 M€ | +1.44% | - | |
| 0.00% | 8 M€ | -0.60% | - | |
| 0.00% | 52 M€ | -0.60% | - | |
| 0.00% | 237 M€ | +2.89% | - |
Sartorius Stedim Biotech is a leading provider of cutting-edge equipment and services for the development, quality assurance and production processes of the biopharmaceutical industry. Its integrated solutions covering fermentation, filtration, purification, fluid management and lab technologies are supporting the biopharmaceutical industry around the world to develop and produce drugs safely, timely and economically.
For next generation processes, Sartorius Stedim Biotech focuses on single-use technologies and value-added services to meet the rapidly changing technology requirements of the industry it serves. Strongly rooted in the scientific community and closely allied with customers and technology partners, the company is dedicated to its philosophy of turning science into solutions on a daily basis.
With its own manufacturing and R&D sites in Europe, North America and Asia and a global network of sales companies, Sartorius Stedim Biotech enjoys a worldwide presence. Its key manufacturing and R&D site is in Germany.
Calendar
2024-05-16
- Capital Markets Day
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
208.3
EUR
Average target price
251.3
EUR
Spread / Average Target
+20.66%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -13.03% | 21.64B | |
| -2.31% | 187B | |
| -3.20% | 106B | |
| -5.04% | 66.9B | |
| +0.20% | 49.45B | |
| +17.29% | 48B | |
| +4.06% | 40.84B | |
| +2.07% | 26.48B | |
| +2.36% | 26.25B | |
| +12.96% | 24.62B |
- Stock Market
- Equities
- DIM Stock
- Funds and ETFs Sartorius Stedim Biotech
